Adjunctive Therapy for the Management of Erectile Dysfunction

Erectile dysfunction (ED) impacts many men and their partners. ED is a symptom caused by organic, inorganic, psychological, and mixed etiologies. The first-line therapy for ED is phosphodiesterase-5 inhibitors (PDE5-I), and many providers limit themselves to its use without implementing other therapeutic options to supplement ED therapy. Clinicians should continue focusing on the underlying cause of ED while concurrently improving erectile function. Implementing other adjuncts can help the patient achieve a firmer erection and improve his and his partner’s sexual wellness. This article reviews other potential adjunctive therapies to supplement the recommended clinical strategies for treating erectile dysfunction. These include activities to improve Nitric Oxide production, pelvic floor exercises, penile therapy, and a combination of other adjuncts to achieve and support improved erectile function